Virbac
Virbac appears in 1 markets tracked by Meridian Consensus across 1 industry (Healthcare). Aggregate market exposure is $77M, computed as the sum of (share × market size) across every appearance.
Its strongest position is Veterinary Urinalysis Market at 7.0% share in a market growing at 5.0% CAGR. Average share across all tracked markets is 7.0%, indicating a meaningful incumbent presence.
Each market page below carries the full Porter Five Forces, SWOT, regional sub-data, regulatory landscape, and competitor table the operator competes against. Use the related-operator rail at the bottom of the page to triangulate Virbac against the peers it actually overlaps with in those segments.
Market positions
Avg share 7.0% · sorted by exposure| Market | Market size | Share | Exposure |
|---|---|---|---|
| Veterinary Urinalysis Market | $1.1B | 7.0% |
Explore adjacent markets
Each market page surfaces Porter Five Forces, SWOT, country analysis, patent filings, regulatory signals, and more, verified against SEC filings, FRED macro series, and trade-association benchmarks.
Operators that compete with Virbac
Peers that show up alongside Virbac in the markets above. Ordered by how many overlapping markets they share — the top of the list is who the operator competes against most directly.